Pfizer (PFE) PT Lowered to $48 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Chris Shibutani lowered the price target on Pfizer (NYSE: PFE) to $48.00 (from $49.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
